Dr. Ron Elfenbein
speaker
860 appearances
1 recordings
1 series
first heard Aug 2026
last heard 3 Aug
Dr. Ron Elfenbein’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsRecordings per month over the last 12 months — 1 in all, peaking in Aug 2026 with 1.
Appearances
It's very frightening.
So there's a new version of this.
There's something called PCSK9, which is something to do with parts of these risks, okay, high cholesterol.
And people with, they have these things called PCSK9 inhibitors that you can inject yourself with that are essentially almost similar to monoclonal antibodies.
And you inject yourself twice a month and it lowers your cholesterol.
They just developed a new version of this using the mRNA technology that you only need to get once because it gets into your cells and it changes the way you express PCSK9.
And they're trying to market this.
Now, some would say, well, that's great because it'll lower my cholesterol the rest of my life and I don't need to do anything.
I don't need to take drugs.
But I don't know about you, but that scares the crap out of me.
I don't want someone messing with my genes.
No, they took them off.
They're not available anymore.
And it's a shame.
Again, so when I go back to 2020, or late 2021, excuse me, when the Biden administration just shut the program down, and just to give you, so you understand what we're talking about here, the rationale that they used in December of 2021, they said, there is an Omicron surge nationwide.
And there was.
But they said the prevalence of the Omicron variant is at 70%.
And once that happens, we're going to shut the program down because these monoclonals don't work against Omicron.
Now, again, as I said earlier, we don't know that for a fact because they never presented any data to suggest that they really don't work against Omicron.
Number two,
Showing 661–680 of 860 · page 34 of 43
← Previous
Next →